Personal Genome Diagnostics, the venture-backed developer of a novel diagnostic kit for genomic profiling of different cancers in lab settings, has received clearance from the U.S. Food and Drug Administration for its PGDx elio tissue complete test.
The test’s approval is another step forward for precision therapies that rely on an understanding of the unique genomic profile of an individual patient’s tumor, according to the company.
Image: Image Credits: Ed Uthman / Flickr (opens in a new window)under a CC BY 2.0 license.
{iframe}https://techcrunch.com/2020/04/27/nea-backed-personal-genome-diagnostics-receives-fda-clearance-for-its-cancer-diagnostic/{/iframe}